64Cu-DOTATATE-PET for Lyme Neuroborreliosis

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

December 31, 2026

Conditions
Borrelia Burgdorferi Neuroborreliosis
Interventions
DIAGNOSTIC_TEST

Cu DOTATATE PET

The primary endpoint of the study is diagnostic performance for detecting LNB by 64Cu-DOTATATE-PET/CT/MRI measured as the difference in uptake between patients with definite LNB and patients without LNB. The primary read-out from 64Cu-DOTATATE-PET/CT/MRI is SUV in CNS and reference organs

Trial Locations (1)

2100

RECRUITING

Anne-Mette Lebech, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER